Tag: OTC Market

Listing vs. Settlement – Dupe

We are very pleased to announce that Erik Nelson, President of Coral Capital Advisors, recently had the following article, “Listing vs. Settlements – Knowing the Difference and Understanding the Importance of Each” published in the Winter/Spring 2024 edition of Micro-Cap…

Benefits of a US Listing

The Benefits of a US Listing for a Foreign Issuer There is substantial evidence that foreign companies whose shares trade in the United States enjoy a higher valuation than those companies whose shares simply trade in their domestic markets.  The…

New Case Study: Resuming Trading Following a Trading Suspension

New Case Study:  Resuming Trading Following a Trading Suspension Coral Capital Advisors has published a new Case Study: Case Study # 10:  Case Study #10:  Resuming Trading on the OTC Following a Trading Halt In this Case Study we take…

Questions in Request for Comments on Changes to Rule 15c2-11

Questions in Request for Comments on Changes to Rule 15c2-11 A couple of weeks ago, we published an article announcing the Securities and Exchange Commission (SEC) had officially published proposed changes to Rule 15c2-11.  Officially tiled “Publication or Submission of…

Initial Statement on Proposed Changes to Rule 15c2-11

Coral’s Initial Statement on Proposed Changes to Rule 15c2-11 A couple of weeks ago, we published an article announcing the Securities and Exchange Commission (SEC) had officially published proposed changes changes to Rule 15c2-11.  Officially tiled “Publication or Submission of…

The SEC’s Proposed Changes to Rule 15c2-11

The SEC’s Proposed Changes to Rule 15c2-11 The Securities and Exchange Commission (SEC) published on September 25th its proposed changes to Rule 15c2-11.  Officially tiled “Publication or Submission of Quotation Without Specified Information.”  A version of the proposed changes to…